JWH-349
File:JWH-349 structure.png | |
IUPAC Name: | {{{IUPACName}}} |
Other Names: | |
Identifiers | |
CAS Number | |
PubChem | |
ChemSpider | |
SMILES | |
InChI | |
InChIKey | |
StdInChI | |
StdInChIKey | |
Properties | |
Chemical formula | CHNO |
Appearance | |
Density | |
Melting Point | |
Boiling Point | |
Solubility | |
Hazards | |
Main Hazards | |
Flash Point | |
Autoignition Temperature |
JWH-349 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds, which are known for their high affinity and selectivity for the CB2 receptor over the CB1 receptor.
Chemical Structure and Properties[edit | edit source]
JWH-349 is chemically classified as a naphthoylindole, which is a subclass of synthetic cannabinoids. The chemical structure of JWH-349 includes a naphthalene ring system, which is substituted with a methoxy group at the 4-position, and an indole moiety that is substituted with a pentyl chain at the 1-position. The full IUPAC name is 1-(4-Methoxynaphthalen-1-yl)-2-(1-pentylindol-3-yl)ethanone.
Pharmacology[edit | edit source]
JWH-349 is known to bind to the CB2 receptor with high affinity, making it a selective agonist for this receptor subtype. The CB2 receptor is primarily found in the peripheral tissues and is associated with the immune system. Activation of CB2 receptors does not produce the psychoactive effects typically associated with CB1 receptor activation, which is predominantly found in the central nervous system.
Receptor Binding[edit | edit source]
JWH-349 has been shown to have a higher affinity for the CB2 receptor compared to the CB1 receptor. This selectivity makes it a useful compound for studying the role of CB2 receptors in various physiological and pathological processes.
Effects[edit | edit source]
Due to its selectivity for the CB2 receptor, JWH-349 is primarily used in research settings to explore the potential therapeutic benefits of CB2 receptor activation, such as anti-inflammatory and immunomodulatory effects. It does not produce the psychoactive effects associated with CB1 receptor activation.
Legal Status[edit | edit source]
The legal status of JWH-349 varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other synthetic cannabinoids that have been associated with recreational use and potential health risks.
Research Applications[edit | edit source]
JWH-349 is used in scientific research to investigate the role of CB2 receptors in various biological processes. It is particularly valuable in studies focused on the immune system, inflammation, and potential therapeutic applications of CB2 receptor agonists.
Safety and Toxicology[edit | edit source]
As with many synthetic cannabinoids, the safety profile of JWH-349 is not well-established. Research is ongoing to determine its potential toxicological effects and long-term safety.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD